These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8056007)

  • 1. Ridogrel does not increase the speed and rate of coronary recanalization in patients with myocardial infarction treated with alteplase and heparin.
    Tranchesi B; Pileggi F; Vercammen E; Van de Werf F; Verstraete M
    Eur Heart J; 1994 May; 15(5):660-4. PubMed ID: 8056007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ridogrel as an adjunct to thrombolysis in acute myocardial infarction.
    van der Wieken LR; Simoons ML; Laarman GJ; Van den Brand M; Nijssen KM; Dellborg M; Hermens W; Vrolik W
    Int J Cardiol; 1995 Nov; 52(2):125-34. PubMed ID: 8749872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT).
    Circulation; 1994 Feb; 89(2):588-95. PubMed ID: 8313547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined thromboxane A2 synthase inhibition and prostaglandin endoperoxide receptor antagonism limits myocardial infarct size after mechanical coronary occlusion and reperfusion at doses enhancing coronary thrombolysis by streptokinase.
    Vandeplassche G; Hermans C; Somers Y; Van de Werf F; de Clerck F
    J Am Coll Cardiol; 1993 Apr; 21(5):1269-79. PubMed ID: 8459087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).
    Arnout J; Simoons M; de Bono D; Rapold HJ; Collen D; Verstraete M
    J Am Coll Cardiol; 1992 Sep; 20(3):513-9. PubMed ID: 1512327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
    Tranchesi B; Chamone DF; Cobbaert C; Van de Werf F; Vanhove P; Verstraete M
    Am J Cardiol; 1991 Jul; 68(2):161-5. PubMed ID: 1829574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD; Keltai M; Walsh MJ
    Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ridogrel in the setting of percutaneous transluminal coronary angioplasty.
    Timmermans C; Vrolix M; Vanhaecke J; Stammen F; Piessens J; Vercammen E; De Geest H
    Am J Cardiol; 1991 Aug; 68(5):463-6. PubMed ID: 1872272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of alteplase for myocardial infarction in two community hospitals.
    Krichbaum DW; Grabavoy G; Finley RC; Hamid I
    Am J Hosp Pharm; 1990 Jul; 47(7):1535-40. PubMed ID: 2114788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction.
    Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C
    Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial.
    de Bono DP; Simoons ML; Tijssen J; Arnold AE; Betriu A; Burgersdijk C; López Bescos L; Mueller E; Pfisterer M; Van de Werf F
    Br Heart J; 1992 Feb; 67(2):122-8. PubMed ID: 1540431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rapidity of coronary recanalization in men with tenecteplase versus alteplase in acute myocardial infarction.
    Binbrek AS; Rao NS; Neimane D; Hatou E; Abdulali S; Sobel BE
    Am J Cardiol; 2004 Jun; 93(12):1465-8. PubMed ID: 15194014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of late potentials after myocardial infarction treated with systemic thrombolysis or primary percutaneous transluminal coronary angioplasty.
    Bruna C; Rossetti G; Vado A; Racca E; Steffenino G; Dellavalle A; Ribichini F; Ferrero V; Menardi E; Uslenghi E
    G Ital Cardiol; 1998 Jan; 28(1):3-11. PubMed ID: 9493040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early intravenous beta-blocker combined with thrombolytic therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI-2) Trial.
    Borzak S; Gheorghiade M
    Prog Cardiovasc Dis; 1993; 36(3):261-6. PubMed ID: 8234778
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.
    Willerson JT; Golino P; McNatt J; Eidt J; Yao SK; Buja LM
    Mol Biol Med; 1991 Apr; 8(2):235-43. PubMed ID: 1806765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retreatment with alteplase for early signs of reocclusion after thrombolysis. The European Cooperative Study Group.
    Simoons ML; Arnout J; van den Brand M; Nÿssen K; Verstraete M
    Am J Cardiol; 1993 Mar; 71(7):524-8. PubMed ID: 8438737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.